Industri Perikanan Jepang Ditinjau dari Perspektif Tata Kelola Global

Abstract Japan is one of the largest consumers of fishery products in the world. Fisheries play a significant role as a key regional economy, especially for coastal areas. In addition, Japan is also one of the largest exporting countries in the world. In meeting market needs and high consumption, a large supply of fish is needed. However, the methods used by the Japanese seem sadistic and inhumane. Dolphin and whale hunting is considered to be so intense in Japan that it produces a 'domino effect'. Where the hunters started their slaughter from the largest dolphin population to the smaller dolphin population. Japan's actions, which still carry out commercial whaling and dolphin hunting, have drawn criticism from anti-whaling countries. There are many regulations governing this phenomenon, the International Convention for the Regulation of Whaling (ICRW) is one of the regulations issued to reduce overexploitation of whale and small cetacean fishing. However, of the many regulations that exist, there is not a single regulation that is heeded by Japan. In full, this study uses a global governance approach as a reference in interpreting a phenomenon being discussed. So this approach was chosen as the focal point in examining the concept of the role of international political institutions and organizations. Where the apparatus and government have a role in hiding the phenomenon of illegal fishing, especially what happened in Taiji, Japan. Keywords: Illegal Fishing; Fishing Net; Fishing Industry; Climate Change; Environmental Indicators; Global Governanc

Industri Perikanan Jepang Ditinjau dari Perspektif Tata Kelola Global

Abstract Japan is one of the largest consumers of fishery products in the world. Fisheries play a significant role as a key regional economy, especially for coastal areas. In addition, Japan is also one of the largest exporting countries in the world. In meeting market needs and high consumption, a large supply of fish is needed. However, the methods used by the Japanese seem sadistic and inhumane. Dolphin and whale hunting is considered to be so intense in Japan that it produces a 'domino effect'. Where the hunters started their slaughter from the largest dolphin population to the smaller dolphin population. Japan's actions, which still carry out commercial whaling and dolphin hunting, have drawn criticism from anti-whaling countries. There are many regulations governing this phenomenon, the International Convention for the Regulation of Whaling (ICRW) is one of the regulations issued to reduce overexploitation of whale and small cetacean fishing. However, of the many regulations that exist, there is not a single regulation that is heeded by Japan. In full, this study uses a global governance approach as a reference in interpreting a phenomenon being discussed. So this approach was chosen as the focal point in examining the concept of the role of international political institutions and organizations. Where the apparatus and government have a role in hiding the phenomenon of illegal fishing, especially what happened in Taiji, Japan. Keywords: Illegal Fishing; Fishing Net; Fishing Industry; Climate Change; Environmental Indicators; Global Governanc

Effect of azithromycin on incidence of acute respiratory exacerbations in children with HIV taking antiretroviral therapy and co-morbid chronic lung disease: a secondary analysis of the BREATHE trial

Background - In the BREATHE trial weekly azithromycin decreased the rate of acute respiratory exacerbations (AREs) compared to placebo among children and adolescents with HIV-associated chronic lung disease (CLD) taking antiretroviral therapy (ART). The aim of this analysis was to identify risk factors associated with AREs and mediators of the effect of azithromycin on AREs. Methods - The primary outcome of this analysis was the rate of AREs by study arm up to 49 weeks. We analysed rates using Poisson regression with random intercepts. Interaction terms were fitted for potential effect modifiers. Participants were recruited from Zimbabwe and Malawi between15 June 2016 and 4 September 2018. Findings - We analysed data from 345 participants (171 allocated to azithromycin and 174 allocated to placebo). Rates of AREs were higher among those with an abnormally high respiratory rate at baseline (adjusted rate ratio (aRR) 2.08 95% CI 1.10-3.95 p-value 0.02) and among those with a CD4 cell count -2 and participants without baseline resistance to azithromycin. However, there was no statistical evidence for interaction due to low statistical power. Interpretation - These may represent subgroups who may benefit the most from treatment with weekly azithromycin, which could help guide targeted treatment. Funding - There was no funding source for this post hoc analysis

Tracing the Rise of Ants - Out of the Ground

We thank S.G. Brady, T.R. Schultz, B.L. Fisher and P.S. Ward for making original data available for re-analysis. P.S. Ward, M. Borowiec and J.K. Lattke provided input regarding habitat strata of the ant genera. J. Hunt provided input regarding the natural history of outgroup taxa. We thank J. Breinholt for technical assistance with analyses and express our appreciation to B. O'Meara, B.M. Wiegmann, Editor C.S. Moreau and two excellent reviewers for their insightful suggestions that significantly improved the manuscript.Conceived and designed the experiments: AL MDT BG MDW RRD. Performed the experiments: AL MDT. Analyzed the data: AL MDT. Contributed reagents/materials/analysis tools: AL MDT BG MDW RRD. Wrote the paper: AL MDT RRD.The evolution of ants (Hymenoptera: Formicidae) is increasingly well-understood due to recent phylogenetic analyses, along with estimates of divergence times and diversification rates. Yet, leading hypotheses regarding the ancestral habitat of ants conflict with new findings that early ant lineages are cryptic and subterranean. Where the ants evolved, in respect to habitat, and how habitat shifts took place over time have not been formally tested. Here, we reconstruct the habitat transitions of crown-group ants through time, focusing on where they nest and forage (in the canopy, litter, or soil). Based on ancestral character reconstructions, we show that in contrast to the current consensus based on verbal arguments that ants evolved in tropical leaf litter, the soil is supported as the ancestral stratum of all ants. We also find subsequent movements up into the litter and, in some cases, into the canopy. Given the global importance of ants, because of their diversity, ecological influence and status as the most successful eusocial lineage on Earth, understanding the early evolution of this lineage provides insight into the factors that made this group so successful today.Yeshttp://www.plosone.org/static/editorial#pee

A rapid biodiversity assessment of Papua New Guinea's Hindenburg Wall Region

[Extract] Aim: The Hindenburg Wall, along with the Muller Range and Nakanai Mountains, is a part of a proposed UNESCO World Heritage Site called The Sublime Karst of Papua New Guinea (Hamilton-Smith 2006). This survey document reports on a biodiversity assessment undertaken by the Wildlife Conservation Society Papua New Guinea (WCS), financed by the Papua New Guinea Sustainable Development Program Ltd (PNGSDP), and undertaken in partnership with the Papua New Guinea Department of Environment and Conservation (DEC). The aim of this project was to conduct a series of biological surveys in the region by a WCS-led team of international and nationaltaxonomic experts in order to investigate the biodiversity values in light of the area being a proposed UNESCO World Heritage Area

NACCHO Exchange: Health Equity

Essential Elements of Health Equity Practice: Partnering to Support Power-Building; Revitalizing Communities: Partnerships to Create Active, Safe Places in Merced County, California; Advancing Health Equity through Regional Collaboration; and Governing for Racial Equity: A Local Health Department's Journe

Adherence to additional medication for management of HIV-associated comorbidities among older children and adolescents taking antiretroviral therapy.

BACKGROUND: Management of co-morbidities among persons living with HIV is an emerging priority, which may require additional medication over and above life-long antiretroviral therapy (ART). We explored factors associated with adherence to the trial drug among children and adolescents with perinatally acquired HIV taking antiretroviral therapy (ART) in the Bronchopulmonary Function in Response to Azithromycin Treatment for Chronic Lung Disease in HIV-Infected Children (BREATHE) trial. METHODS: The BREATHE trial recruited 6-19 year olds with perinatally acquired HIV and co-morbid chronic lung disease as measured by FEV1. This two-site trial was individually randomised (1:1), double-blind and placebo-controlled. Participants received a once-weekly weight-based dose of 1-5 tablets of azithromycin (AZM: 250mg) or placebo, taken orally. We used pharmacy dispensing records and count of returned pills to measure adherence to study medication. Logistic regression was used to explore factors associated with adherence coverage. Poisson regression with Lexis expansion for time was used to explore whether adherence modified the effect of azithromycin on the incidence of acute respiratory exacerbation, a secondary outcome of the trial. Trial registration: ClinicalTrials.gov NCT02426112. RESULTS: The 347 participants (median age 15.3, 51% male) consumed 14,622 doses of study medication over 16,220 person-weeks under study. Adherence was higher for those randomised to AZM (73.4%) than placebo (68.4%) and declined over the 48 weeks of the study (Score test for trend <0.02). Those with unsuppressed HIV viral load at baseline had 2.08 (95% CI: 1.19, 3.63) times the odds of non-adherence than those with viral suppression. Differences were also observed between trial sites. CONCLUSION: The majority of children and adolescents tolerated the addition of a once-weekly dose of medication to their pill burden. Barriers in adhering to treatment for co-morbid conditions are likely common to barriers in adhering to ART. Control of co-morbidities will therefore present additional challenges in HIV care

Adherence to additional medication for management of HIV-associated comorbidities among older children and adolescents taking antiretroviral therapy

BACKGROUND : Management of co-morbidities among persons living with HIV is an emerging priority, which may require additional medication over and above life-long antiretroviral therapy (ART). We explored factors associated with adherence to the trial drug among children and adolescents with perinatally acquired HIV taking antiretroviral therapy (ART) in the Bronchopulmonary Function in Response to Azithromycin Treatment for Chronic Lung Disease in HIV-Infected Children (BREATHE) trial. METHODS : The BREATHE trial recruited 6–19 year olds with perinatally acquired HIV and co-morbid chronic lung disease as measured by FEV1. This two-site trial was individually randomised (1:1), double-blind and placebo-controlled. Participants received a once-weekly weightbased dose of 1–5 tablets of azithromycin (AZM: 250mg) or placebo, taken orally. We used pharmacy dispensing records and count of returned pills to measure adherence to study medication. Logistic regression was used to explore factors associated with adherence coverage. Poisson regression with Lexis expansion for time was used to explore whether adherence modified the effect of azithromycin on the incidence of acute respiratory exacerbation, a secondary outcome of the trial. Trial registration: ClinicalTrials.gov NCT02426112. RESULTS : The 347 participants (median age 15.3, 51% male) consumed 14,622 doses of study medication over 16,220 person-weeks under study. Adherence was higher for those randomised to AZM (73.4%) than placebo (68.4%) and declined over the 48 weeks of the study (Score test for trend <0.02). Those with unsuppressed HIV viral load at baseline had 2.08 (95% CI: 1.19, 3.63) times the odds of non-adherence than those with viral suppression. Differences were also observed between trial sites. CONCLUSION : The majority of children and adolescents tolerated the addition of a once-weekly dose of medication to their pill burden. Barriers in adhering to treatment for co-morbid conditions are likely common to barriers in adhering to ART. Control of co-morbidities will therefore present additional challenges in HIV care.The Global Health and Vaccination Research (GLOBVAC) Programme of the Medical Research Council of Norway, the Wellcome Trust, the Medical Research Council (MRC) and the Department for International Development (DFID UK).http://www.plosone.orgdm2022School of Health Systems and Public Health (SHSPH

Risk factors for sustained virological non-suppression among children and adolescents living with HIV in Zimbabwe and Malawi: a secondary data analysis.

BACKGROUND: We investigated risk factors for sustained virological non-suppression (viral load ≥ 1000 copies/ml on two tests 48 weeks apart) among children and adolescents accessing HIV care in public sector clinics in Harare, Zimbabwe and Blantyre, Malawi. METHODS: Participants were enrolled between 2016 and 2019, were aged 6-19 years, living with HIV, had chronic lung disease (FEV z-score < -1) and had taken antiretroviral therapy (ART) for at least six months. We used multivariate logistic regression to identify risk factors for virological non-suppression after 48 weeks, among participants who were non-suppressed at enrolment. RESULTS: At enrolment 258 participants (64.6%) were on first-line ART and 152/347 (43.8%) had virological non-suppression. After 48 weeks 114/313 (36.4%) were non-suppressed. Participants non-suppressed at baseline had almost ten times higher odds of non-suppression at follow-up (OR = 9.9, 95%CI 5.3-18.4, p < 0.001). Of those who were non-suppressed at enrolment, 87/136 (64.0%) were still non-suppressed at 48 weeks. Among this group non-suppression at 48 weeks was associated with not switching ART regimen (adjusted OR = 5.55; 95%CI 1.41-21.83); p = 0.014) and with older age. Twelve participants switched regimen in Zimbabwe and none in Malawi. CONCLUSIONS: Viral non-suppression was high among this group and many with high viral load were not switched to a new regimen, resulting in continued non-suppression after 48 weeks. Further research could determine whether improved adherence counselling and training clinicians on regimen switches can improve viral suppression rates in this population. TRIAL REGISTRATION: Secondary cohort analysis of data from BREATHE trial (Clinicaltrials.gov NCT02426112 )

Risk factors for sustained virological non-suppression among children and adolescents living with HIV in Zimbabwe and Malawi : a secondary data analysis

BACKGROUND: We investigated risk factors for sustained virological non-suppression (viral load≥1000 copies/ml on two tests 48 weeks apart) among children and adolescents accessing HIV care in public sector clinics in Harare, Zimbabwe and Blantyre, Malawi. METHODS: Participants were enrolled between 2016 and 2019, were aged 6–19 years, living with HIV, had chronic lung disease (FEV z-score< -1) and had taken antiretroviral therapy (ART) for at least six months. We used multivariate logistic regression to identify risk factors for virological non-suppression after 48 weeks, among participants who were non-suppressed at enrolment. RESULTS: At enrolment 258 participants (64.6%) were on frst-line ART and 152/347 (43.8%) had virological non-sup‑ pression. After 48 weeks 114/313 (36.4%) were non-suppressed. Participants non-suppressed at baseline had almost ten times higher odds of non-suppression at follow-up (OR=9.9, 95%CI 5.3–18.4, p<0.001). Of those who were nonsuppressed at enrolment, 87/136 (64.0%) were still non-suppressed at 48 weeks. Among this group non-suppression at 48 weeks was associated with not switching ART regimen (adjusted OR=5.55; 95%CI 1.41–21.83); p=0.014) and with older age. Twelve participants switched regimen in Zimbabwe and none in Malawi. CONCLUSION: Viral non-suppression was high among this group and many with high viral load were not switched to a new regimen, resulting in continued non-suppression after 48 weeks. Further research could determine whether improved adherence counselling and training clinicians on regimen switches can improve viral suppression rates in this population.Norwegian Research Council, UK Medical Research Council, UK Foreign, Commonwealth and Development Office.http://www.biomedcentral.com/bmcpediatrSchool of Health Systems and Public Health (SHSPH